Ebola pandemic is at risk of outbreaks in 15 African countries, threatening the lives of 22 million people.
Researchers at the US National Institutes of Health (NIH) are preparing to conduct a human clinical trial of a new prospective Ebola virus vaccine, nearly a month earlier than
The ZMapp method is applied to two American patients infected with Ebola virus, but it has not been recognized as a cure for human body disease and may have potential side effects.
The characteristics of viruses or bacteria that spread the disease make them biological weapons thousands of years ago and are warranted to be used in modern times.